{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T21:12:14Z","timestamp":1768770734737,"version":"3.49.0"},"reference-count":45,"publisher":"BMJ","issue":"1","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Evid Based Mental Health"],"accepted":{"date-parts":[[2017,11,3]]},"published-print":{"date-parts":[[2018,2]]},"abstract":"<jats:sec>\n                  <jats:title>Question<\/jats:title>\n                  <jats:p>Network meta-analyses (NMAs) of treatment efficacy across different pharmacological treatments help inform clinical decision-making, but their methodological quality may vary a lot depending also on the quality of the included primary studies. We therefore conducted a systematic review of NMAs of pharmacological treatment for common mental disorders in order to assess the methodological quality of these NMAs, and to relate study characteristics to the rankings of efficacy and tolerability.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Study selection and analysis<\/jats:title>\n                  <jats:p>We searched three databases for NMAs of pharmacological treatment used in major depression, generalised anxiety disorder (GAD), social anxiety disorder (SAD), post-traumatic stress disorder (PTSD), obsessive-compulsive disorder (OCD) and specific phobia.<\/jats:p>\n                  <jats:p>Studies were appraised using the International Society for Pharmacoeconomics and Outcomes Research checklist of good research practices for indirect-treatment-comparison and network-meta-analysis studies.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Findings<\/jats:title>\n                  <jats:p>Twenty NMAs were eligible for inclusion. The number of randomised controlled trials per NMA ranged from 11 to 234, and included between 801 to more than 26\u2009000 participants. Overall, antidepressants were found to be efficacious and tolerable agents for several disorders based on rankings (45%) or statistical significance (55%). The majority of NMAs in this review adhered to guidelines by including a network diagram (70%), assessing consistency (75%), making use of a random effects model (75%), providing information on the model used to fit the data (75%) and adjusting for covariates (75%).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>The 20 NMAs of depression and anxiety disorders, PTSD and\/or OCD included in this review demonstrate some methodological strengths in comparison with the larger body of published NMAs for medical disorders, support current treatment guidelines and help inform clinical decision-making.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/eb-2017-102718","type":"journal-article","created":{"date-parts":[[2018,1,12]],"date-time":"2018-01-12T12:17:54Z","timestamp":1515759474000},"page":"7-11","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":20,"title":["A systematic review of network meta-analyses for pharmacological treatment of common mental disorders"],"prefix":"10.1136","volume":"21","author":[{"given":"Taryn","family":"Williams","sequence":"first","affiliation":[{"name":"Department of Psychiatry and Mental Health, University of Cape Town, J-2 Groote Schuur Hospital, Cape Town, South Africa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan J","family":"Stein","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Mental Health, University of Cape Town, J-2 Groote Schuur Hospital, Cape Town, South Africa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Ipser","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Mental Health, University of Cape Town, J-2 Groote Schuur Hospital, Cape Town, South Africa"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2018,1,12]]},"reference":[{"key":"2025082702075312000_21.1.7.1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)61611-6"},{"key":"2025082702075312000_21.1.7.2","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyu038"},{"key":"2025082702075312000_21.1.7.3","doi-asserted-by":"publisher","DOI":"10.1002\/mpr.1381"},{"key":"2025082702075312000_21.1.7.4","doi-asserted-by":"publisher","DOI":"10.1177\/0269881114525674"},{"key":"2025082702075312000_21.1.7.5","doi-asserted-by":"publisher","DOI":"10.1017\/S1461145711001209"},{"key":"2025082702075312000_21.1.7.6","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S0140-6736(16)30385-3","article-title":"Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis","volume":"388","author":"Cipriani","year":"2016","journal-title":"Lancet"},{"key":"2025082702075312000_21.1.7.7","doi-asserted-by":"crossref","unstructured":"McCloud TL , Caddy C , Jochim J , et al . Ketamine and other glutamate receptor modulators for depression in bipolar disorder in adults. Cochrane Database Syst Rev 2015(9):CD011611.doi:10.1002\/14651858.CD011611.pub2","DOI":"10.1002\/14651858.CD011611.pub2"},{"key":"2025082702075312000_21.1.7.8","doi-asserted-by":"publisher","DOI":"10.3399\/bjgp12X616481"},{"key":"2025082702075312000_21.1.7.9","unstructured":"World Health Organisation (WHO). Pharmacological treatment of mental disorders in primary health care. Geneva: WHO Library Cataloguing-in-Publication Data, World Health Organization, 2013:1\u201382."},{"key":"2025082702075312000_21.1.7.10","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/jrsm.1195","article-title":"Get real in network meta-analysis: a review of the methodology","volume":"7","author":"Efthimiou","year":"2016","journal-title":"Res Synth Methods"},{"key":"2025082702075312000_21.1.7.11","doi-asserted-by":"publisher","DOI":"10.1136\/eb-2015-102088"},{"key":"2025082702075312000_21.1.7.12","doi-asserted-by":"publisher","DOI":"10.1002\/jrsm.1044"},{"key":"2025082702075312000_21.1.7.13","doi-asserted-by":"publisher","DOI":"10.1136\/eb-2014-101967"},{"key":"2025082702075312000_21.1.7.14","doi-asserted-by":"publisher","DOI":"10.1002\/jrsm.1037"},{"key":"2025082702075312000_21.1.7.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2011.04.002"},{"key":"2025082702075312000_21.1.7.16","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s40273-014-0138-x","article-title":"Cost-effectiveness analysis of pharmaceutical treatment options in the first-line management of major depressive disorder in Belgium","volume":"32","author":"Annemans","year":"2014","journal-title":"Pharmacoeconomics"},{"key":"2025082702075312000_21.1.7.17","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/S2215-0366(14)70329-3","article-title":"Psychological and pharmacological interventions for social anxiety disorder in adults: a systematic review and network meta-analysis","volume":"1","author":"Mayo-Wilson","year":"2014","journal-title":"Lancet Psychiatry"},{"key":"2025082702075312000_21.1.7.18","doi-asserted-by":"publisher","DOI":"10.1370\/afm.1687"},{"key":"2025082702075312000_21.1.7.19","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1136\/eb-2017-102753","article-title":"Common pitfalls and mistakes in the set-up, analysis and interpretation of results in network meta-analysis: what clinicians should look for in a published article","volume":"20","author":"Chaimani","year":"2017","journal-title":"Evid Based Ment Helath"},{"key":"2025082702075312000_21.1.7.20","unstructured":"Jonas DE , Cusack K , Forneris CA , et al . Psychological and Pharmacological Treatments for Adults with Posttraumatic Stress Disorder (PTSD). Comparative Effectiveness Review No. 92. (Prepared by the RTI International\u2013University of North Carolina Evidence-based Practice Center under Contract No. 290-2007-10056-I.) AHRQ Publication No. 13-EHC011-EF. Rockville, MD: Agency for Healthcare Research and Quality, 2013. ww.effectivehealthcare.ahrq.gov\/reports\/final.cfm"},{"key":"2025082702075312000_21.1.7.21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0099682","article-title":"Evaluating the quality of evidence from a network meta-analysis","volume":"9","author":"Salanti","year":"2014","journal-title":"PLoS One"},{"key":"2025082702075312000_21.1.7.22","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jclinepi.2016.11.002","article-title":"Bibliographic study showed improving statistical methodology of network meta-analyses published between 1999 and 2015","volume":"82","author":"Petropoulou","year":"2017","journal-title":"J Clin Epidemiol"},{"key":"2025082702075312000_21.1.7.23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0063509","article-title":"Efficacy of new generation antidepressants: differences seem illusory","volume":"8","author":"Del Re","year":"2014","journal-title":"PLoS One"},{"key":"2025082702075312000_21.1.7.24","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-155-11-201112060-00009"},{"key":"2025082702075312000_21.1.7.25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0121715","article-title":"An assessment of the methodological quality of published network meta-analyses: a systematic review","volume":"10","author":"Chambers","year":"2015","journal-title":"PLoS One"},{"key":"2025082702075312000_21.1.7.26","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12916-016-0764-6","article-title":"Characteristics and knowledge synthesis approach for 456 network meta-analyses: a scoping review","volume":"15","author":"Zarin","year":"2017","journal-title":"BMC Med"},{"key":"2025082702075312000_21.1.7.27","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)60046-5"},{"key":"2025082702075312000_21.1.7.28","doi-asserted-by":"publisher","DOI":"10.1002\/da.22236"},{"key":"2025082702075312000_21.1.7.29","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/1741-7015-12-105","article-title":"Placebo for depression: we need to improve the quality of scientific information but also reject too simplistic approaches or ideological nihilism","volume":"12","author":"Cipriani","year":"2014","journal-title":"BMC Med"},{"key":"2025082702075312000_21.1.7.30","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-014-0169-z"},{"key":"2025082702075312000_21.1.7.31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0076651","article-title":"Comparative efficacy and acceptability of antidepressants in Parkinson\u2019s disease: a network meta-analysis","volume":"8","author":"Liu","year":"2013","journal-title":"PLoS One"},{"key":"2025082702075312000_21.1.7.32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0042003","article-title":"Effectiveness and cost-effectiveness of antidepressants in primary care: a multiple treatment comparison meta-analysis and cost-effectiveness model","volume":"7","author":"Ramsberg","year":"2012","journal-title":"PLoS One"},{"key":"2025082702075312000_21.1.7.33","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s40264-013-0129-4","article-title":"Sexual dysfunction associated with second-generation antidepressants in patients with major depressive disorder: results from a systematic review with network meta-analysis","volume":"37","author":"Reichenpfader","year":"2014","journal-title":"Drug Saf"},{"key":"2025082702075312000_21.1.7.34","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1017\/S1092852912000648","article-title":"An indirect comparison of the efficacy and safety of desvenlafaxine and venlafaxine using placebo as the common comparator","volume":"17","author":"Coleman","year":"2012","journal-title":"CNS Spectr"},{"key":"2025082702075312000_21.1.7.35","doi-asserted-by":"crossref","first-page":"e487","DOI":"10.4088\/JCP.14r09204","article-title":"Comparative efficacy, acceptability, and tolerability of augmentation agents in treatment-resistant depression: systematic review and network meta-analysis","volume":"76","author":"Zhou","year":"2015","journal-title":"J Clin Psychiatry"},{"key":"2025082702075312000_21.1.7.36","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1080\/03007995.2016.1277201","article-title":"Comparative efficacy and tolerability of pharmacological and somatic interventions in adult patients with treatment-resistant depression: a systematic review and network meta-analysis","volume":"33","author":"Papadimitropoulou","year":"2017","journal-title":"Curr Med Res Opin"},{"key":"2025082702075312000_21.1.7.37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0153380","article-title":"Comparative Safety of Pharmacologic Treatments for Persistent Depressive Disorder: A Systematic Review and Network Meta-Analysis","volume":"11","author":"Meister","year":"2016","journal-title":"PLoS One"},{"key":"2025082702075312000_21.1.7.38","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s40273-013-0031-z","article-title":"The cost effectiveness of pharmacological treatments for generalized anxiety disorder","volume":"31","author":"Mavranezouli","year":"2013","journal-title":"Pharmacoeconomics"},{"key":"2025082702075312000_21.1.7.39","doi-asserted-by":"publisher","DOI":"10.1097\/YIC.0b013e3282f4224a"},{"key":"2025082702075312000_21.1.7.40","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/S2215-0366(16)30069-4","article-title":"Pharmacological and psychotherapeutic interventions for management of obsessive-compulsive disorder in adults: a systematic review and network meta-analysis","volume":"3","author":"Skapinakis","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"2025082702075312000_21.1.7.41","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-0009.2010.00598.x"},{"key":"2025082702075312000_21.1.7.42","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-12-150"},{"key":"2025082702075312000_21.1.7.43","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-9-79"},{"key":"2025082702075312000_21.1.7.44","doi-asserted-by":"publisher","DOI":"10.1007\/s00406-016-0715-4"},{"key":"2025082702075312000_21.1.7.45","unstructured":"World Health Organisation (WHO). Health technology assessment of medical devices. WHO Medical device technical series. 2011:1\u201344 http:\/\/apps.who.int\/medicinedocs\/en\/d\/Js21560en\/ (accessed on 2 Nov 2017)."}],"container-title":["Evidence Based Mental Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/eb-2017-102718","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T09:08:01Z","timestamp":1756285681000},"score":1,"resource":{"primary":{"URL":"https:\/\/mentalhealth.bmj.com\/lookup\/doi\/10.1136\/eb-2017-102718"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,12]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,1,23]]},"published-print":{"date-parts":[[2018,2]]}},"alternative-id":["10.1136\/eb-2017-102718"],"URL":"https:\/\/doi.org\/10.1136\/eb-2017-102718","relation":{},"ISSN":["1362-0347","1468-960X"],"issn-type":[{"value":"1362-0347","type":"print"},{"value":"1468-960X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,12]]}}}